Cargando…

No effect of vitamin D supplementation on cardiovascular risk factors in subjects with metabolic syndrome: a pilot randomised study

INTRODUCTION: Patients with metabolic syndrome (MetS) may have lower 25-hydroxyvitamin D (25(OH)VitD) serum levels compared with non-MetS individuals. Vitamin D (VitD) deficiency is associated with various cardiovascular disease (CVD) risk factors. Yet, the effect of VitD supplementation on MetS rem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Makariou, Stefania E., Elisaf, Moses, Challa, Anna, Tentolouris, Nikolaos, Liberopoulos, Evangelos N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2017
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728078/ https://www.ncbi.nlm.nih.gov/pubmed/29242845 http://dx.doi.org/10.5114/amsad.2017.70504

Ejemplares similares

The relationship of vitamin D with non-traditional risk factors for cardiovascular disease in subjects with metabolic syndrome
por: Makariou, Stefania, et al.
Publicado: (2012)

Vitamin D status and cardiometabolic risk factors in Greek adolescents with obesity – the effect of vitamin D supplementation: a pilot study
por: Makariou, Stefania E., et al.
Publicado: (2020)

Statin escape phenomenon: Fact or fiction?
por: Barkas, Fotios, et al.
Publicado: (2017)

No effect of fenugreek, bergamot and olive leaf extract on glucose homeostasis in patients with prediabetes: a randomized double-blind placebo-controlled study
por: Florentin, Matilda, et al.
Publicado: (2019)

Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study
por: Athyros, Vassilios G., et al.
Publicado: (2011)

Effects of increased body weight and short-term weight loss on serum PCSK9 levels – a prospective pilot study
por: Filippatos, Theodosios D, et al.
Publicado: (2017)

Add-on-Statin Extended Release Nicotinic Acid/Laropiprant but Not the Switch to High-Dose Rosuvastatin Lowers Blood Pressure: An Open-Label Randomized Study
por: Kei, Anastazia, et al.
Publicado: (2011)

Life-threatening hypophosphataemia in a cirrhotic patient with jaundice
por: Moutzouri, Elisavet, et al.
Publicado: (2011)

COVID-19 and diabetes: What does the clinician need to know?
por: Papadokostaki, Eleni, et al.
Publicado: (2020)

Electrolyte and acid-base disorders in inflammatory bowel disease
por: Barkas, Fotis, et al.
Publicado: (2013)

Differences in metabolic parameters and cardiovascular risk between American Diabetes Association and World Health Organization definition of impaired fasting glucose in European Caucasian subjects: a cross-sectional study
por: Filippatos, Theodosios D., et al.
Publicado: (2013)

Attainment of multifactorial treatment targets among the elderly in a lipid clinic
por: Barkas, Fotios, et al.
Publicado: (2015)

Effects of Eprosartan on Serum Metabolic Parameters in Patients with Essential Hypertension
por: Rizos, Evangelos C, et al.
Publicado: (2007)

The Role of Vitamin D in Health and Disease: A Narrative Review on the Mechanisms Linking Vitamin D with Disease and the Effects of Supplementation
por: Rebelos, Eleni, et al.
Publicado: (2023)

Attainment of cholesterol target values in Greece: results from the Dyslipidemia International Study II
por: Liberopoulos, Evangelos, et al.
Publicado: (2018)

The effect of combining rosuvastatin with sartans of different peroxisome proliferator receptor-γ activating capacity on plasma 8-isoprostane prostaglandin F(2a) levels
por: Rizos, Christos V., et al.
Publicado: (2013)

Fenofibrate in Primary Biliary Cirrhosis: A Pilot Study
por: Liberopoulos, E.N, et al.
Publicado: (2010)

Vitamin D supplementation and major cardiovascular events: D-Health randomised controlled trial
por: Thompson, Bridie, et al.
Publicado: (2023)

Nicotinic acid/laropiprant reduces platelet count but increases mean platelet volume in patients with primary dyslipidemia
por: Kei, Anastazia, et al.
Publicado: (2014)

Effect of α-lipoic acid on symptoms and quality of life in patients with painful diabetic neuropathy
por: Agathos, Evangelos, et al.
Publicado: (2018)

Obstructive sleep apnoea syndrome and cardiovascular risk
por: Kostapanos, Michael S., et al.
Publicado: (2012)

Reduced Serum Vitamin D Levels Are Associated with Insulin Resistance in Patients with Obstructive Sleep Apnea Syndrome
por: Archontogeorgis, Kostas, et al.
Publicado: (2019)

The Association between Polymorphisms of Vitamin D Metabolic-Related Genes and Vitamin D(3) Supplementation in Type 2 Diabetic Patients
por: Hu, Zhiyong, et al.
Publicado: (2019)

Effects of Thyroid Dysfunction on Lipid Profile
por: Rizos, C.V, et al.
Publicado: (2011)

Supplementation with High Doses of Vitamin D to Subjects without Vitamin D Deficiency May Have Negative Effects: Pooled Data from Four Intervention Trials in Tromsø
por: Jorde, Rolf, et al.
Publicado: (2013)

Current data on the cardiovascular effects of COVID-19
por: Vlachakis, Panayotis K., et al.
Publicado: (2020)

Effects of daily vitamin D supplementation on respiratory muscle strength and physical performance in vitamin D-deficient COPD patients: a pilot trial
por: Rafiq, Rachida, et al.
Publicado: (2017)

Serum Vitamin D Levels and Vitamin D Supplement in Adult Patients with Asthma Exacerbation
por: Boonpiyathad, Tadech, et al.
Publicado: (2016)

Randomised controlled trial of vitamin D supplementation in sarcoidosis
por: Bolland, Mark J, et al.
Publicado: (2013)

Adherence to the National Guidelines for Follow-Up Protocol in Subjects with Type 2 Diabetes Mellitus in Greece: The GLANCE Study
por: Papanas, Nikolaos, et al.
Publicado: (2020)

Glucose Metabolism Effects of Vitamin D in Prediabetes: The VitDmet Randomized Placebo-Controlled Supplementation Study
por: Tuomainen, Tomi-Pekka, et al.
Publicado: (2015)

Cardiac Autonomic Neuropathy Predicts All-Cause and Cardiovascular Mortality in Patients With End-Stage Renal Failure: A 5-Year Prospective Study
por: Doulgerakis, Dimitrios, et al.
Publicado: (2017)

A review of drug-induced hypernatraemia
por: Liamis, George, et al.
Publicado: (2009)

The Role of Diabetes and Hyperglycemia on COVID-19 Infection Course—A Narrative Review
por: Tzeravini, Evangelia, et al.
Publicado: (2022)

Difficulties in designing randomised controlled trials of vitamin D supplementation for reducing acute cardiovascular events and in the analysis of their outcomes
por: Boucher, Barbara J., et al.
Publicado: (2020)

Effects of Vitamin D Supplementation on Cardiovascular and Glycemic Biomarkers
por: Miao, Jennifer, et al.
Publicado: (2021)

Vitamin D supplementation does not improve CVD risk factors in vitamin D-insufficient subjects
por: Kubiak, Julia, et al.
Publicado: (2018)

Diet and Cardiovascular Disease Risk Among Individuals with Familial Hypercholesterolemia: Systematic Review and Meta-Analysis
por: Barkas, Fotios, et al.
Publicado: (2020)

Statin-associated side effects in patients attending a lipid clinic: evidence from a 6-year study
por: Barkas, Fotios, et al.
Publicado: (2021)

Effect of supplementation with vitamin D(2)-enhanced mushrooms on vitamin D status in healthy adults
por: Stepien, Magdalena, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_vr1cf6t3qj45i43e75h31ouc1c